A new study done by reveals that during menopausal state in women, high hip bone density may help in estimating the risk of developing breast cancer.

According to Food and Drug Administration (FDA) several studies on Bevacizumab (Avastin,Genetech,Inc) plus Sunitinib Malate (Sutent, Pfizer, Inc) have been halted due to the reports of Microangiopathic hemolytic anemia (MAHA).

Recent study in breast cancer suggests that taking one aspirin daily may reduce the development of breast cancer up to 16%.

Researchers at Washington University School of Medicine and Alberta Cancer Board have found that physical activity reduces the risk of breast cancer among both the pre and post menopausal women. The two studies have proved that regular physical activity can reduce at least 23% of the risk of the disease.

Researchers from Research Institute of the MUHC and McGill University have identified environment surrounding breast cancer cells plays a crucial role in determining whether tumor cells grow and migrate or whether they fade away. The study, published in Nature Medicine, show that a tumor needs the support of the micro environment. The study show [...]